Trial intelligence / Profile preview

Switching From Morphine to Methadone in Cancer Pain

NCT00184496Phase 3Completed

Sponsor
Norwegian University of Science and Technology
Start
Aug 2004
Primary completion
Sep 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methadone in cancer pain, sponsored by Norwegian University of Science and Technology. Started Aug 2004; status: completed.

02

Drugs

methadone
03

Conditions

cancer pain

Beyond the preview

Go deeper on NCT00184496.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00184496.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call